Indonesia receives Janssen vaccine from the Netherlands and first delivery of Dose-Sharing to France
Jakarta. Indonesia received a shipment of 500,000 doses of Janssen vaccine from the Netherlands on Saturday, following a batch of AstraZeneca vaccine from France a day earlier, as part of the countries’ vaccine sharing program European countries aiming to increase the vaccination rate in the world.
The Netherlands and France have pledged to send up to 3 million doses of vaccine each to Indonesia as part of their vaccine-sharing initiative with developing countries around the world.
“This is the third time that Dutch cooperation has taken place. Previously, Indonesia had received 657,000 doses of AstraZeneca vaccine from the Netherlands as part of a dose-sharing pledge from the Netherlands up to three million doses, “Foreign Minister Retno said on Saturday. LP Marsudi in a press release.
On Friday, a batch of 358,700 doses of AstraZeneca vaccine arrived in Indonesia, the first delivery from France via Covax / Gavi, a WHO-supported program for the global distribution of vaccines. Previously, the United States, Japan and Australia also shared their vaccines with Indonesia.
The World Health Organization (WHO) had asked developed countries to distribute their surplus vaccines to the rest of the world to address the global vaccine imbalance.
Retno said 80% of the 5.5 billion Covid-19 vaccines shipped worldwide so far were in middle and high-income countries, which had acted early to secure vaccine supplies to producers.
The Economist reported that only 2 percent of adults in low-income countries are fully immunized today, far less than 50 percent in high-income countries. The publication also noted that between 1 million and 2.8 million lives could die if rich countries kept their vaccine surplus this year, citing an analysis by Airfinity, a life sciences data company.
Unvaccinated populations, especially in low- and middle-income countries, are believed to be fertile ground for SARS-CoV-2, a coronavirus that has caused the uncontrolled spread of Covid-19, allowing it to mutate into more ferocious variants , warned the WHO.
It is therefore essential to vaccinate as many people as possible as quickly as possible to avoid such a scenario. Retno said the WHO has targeted at least 10 percent of the population in each country would have been vaccinated by the end of September 2021 through the dose-sharing initiative.
First Jenssen delivery
The Janssen delivery on Saturday was the first of its kind in Indonesia. Until today, all stocks in the country consist of vaccines that had to be delivered twice to be effective. This complicates the logistics of vaccines, especially in the most remote area of the archipelago.
The Ambassador of the Kingdom of the Netherlands to the Republic of Indonesia, Lambert Grijns, said the Janssen vaccine would be ideal for vaccinating people in remote areas, as health workers only need to do one travel to deliver them, he said in the statement.
The Food and Drug Supervisory Agency (BPOM) issued an Emergency Use Authorization (EUA) for the Janssen vaccine last Tuesday. The agency said the Janssen vaccine was 66.1% effective in preventing moderate to critical symptoms of Covid-19. The effectiveness was slightly higher, 67.2%, in preventing any symptoms of Covid-19.
The Janssen Covid-19 vaccine is a vaccine developed by the Janssen Pharmaceutical Companies, using adenovirus (Ad26) as a non-replicative viral vector platform.